X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.marinomed.com/en/news/marinomed-and-friedrich-alexander-universitaet-erlangen-nuernberg-publish-new-data-on-antiviral-efficacy-of-iota-carrageenan-against-sars-cov-2-variants-of-concern
https://www.biospace.com/article/releases/luoxin-pharmaceutical-signs-licensing-agreement-with-austria-based-marinomed-biotech-ag-for-budesolv-budesonide-nasal-spray/?s=71
https://www.dgap.de/dgap/News/corporate/first-marinosolvr-platform-deal-marinomed-biotech-and-luoxin-pharmaceutical-group-stock-ltd-sign-agreement-budesolv-treat-allergic-rhinitis-greater-china/?newsID=1482231
https://uk.sports.yahoo.com/news/marinomed-biotech-ag-signs-financing-054503953.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAANUsXKp9EV_pcyS_VIUg7e4eJ-eOwn2bJxb8C2svbZJ-J1mitX4RLqg5F7W1E8OiQdP-34rt4O1z2gAUUQo7JNuJp10129dyiSDB6Pa0RFP8EmTcLAXOKQvKK0-LgGJ6cr7DBdk3wIWAeJ79QyPnwAwlM4PMcJ-tEYH0-5qh2qJN
https://www.bloomberg.com/press-releases/2021-08-25/dgap-news-marinomed-biotech-ag-reports-financial-results-for-1st-half-2021-with-significant-revenue-growth
https://www.prnewswire.com/news-releases/marinomed-biotech-ag-grants-exclusive-rights-for-carragelose-to-m8-pharmaceuticals-marketed-locally-as-barlo-301326144.html
https://www.prnewswire.com/news-releases/marinomed-biotech-ag-grants-exclusive-rights-for-carragelose-to-m8-pharmaceuticals-marketed-locally-as-barlo-301326144.html
https://www.dgap.de/dgap/News/corporate/marinomed-biotech-reports-encouraging-topline-data-for-phase-clinical-trial-tacrosolv-allergic-rhinoconjunctivitis/?newsID=1460346
http://www.pharmabiz.com/NewsDetails.aspx?aid=137948&sid=2#:~:text=%2B%20Font%20Resize%20%2D-,Marinomed%20Biotech%20announces%20positive%20data%20demonstrating,against%20SARS%2DCoV%2D2%20variants&text=Given%20the%20broad%20antiviral%20efficacy,the%20antiviral%20efficacy%20of%20Carragelose.
https://www.marinomed.com/en/news/marinomed-biotech-ag-reports-financial-results-for-fiscal-year-2020-and-record-sales-for-virus-blocker-carragelose
Market Place
Share 
